Literature DB >> 336314

Indications and contra-indications for perforation keratoplasty.

C C Kok-van Alphen, H J Völker-Dieben.   

Abstract

Thirty years' experience with perforating keratoplasty has shown us new indications for this technique, but certainly also new contra-indications. At first the prognosis of perforating keratoplasty improved because of better surgical techniques, so that the number of indications increased. Recently a better prognosis for heavily vascularized eyes has become possible thanks to HLA-matched donor material.

Entities:  

Mesh:

Year:  1977        PMID: 336314     DOI: 10.1007/bf00171453

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  8 in total

1.  Perforating corneal transplantation: difficulties and possibilities.

Authors:  C C Kok-van Alphen
Journal:  Ophthalmologica       Date:  1975       Impact factor: 3.250

2.  The prognosis of penetrating keratoplasty based upon corneal morphology.

Authors:  D Paton
Journal:  Ophthalmic Surg       Date:  1976

3.  [Perforating keratoplasty in aphakia (author's transl)].

Authors:  H J Meyer
Journal:  Klin Monbl Augenheilkd       Date:  1974-04       Impact factor: 0.700

4.  Complications of keratoplasty.

Authors:  A G DeVoe
Journal:  Am J Ophthalmol       Date:  1975-06       Impact factor: 5.258

5.  [Keratoplasty based on acute indication (author's transl)].

Authors:  W Hallermann
Journal:  Klin Monbl Augenheilkd       Date:  1975-09       Impact factor: 0.700

6.  [Suture technique for perforating keratoplasty (author's transl)].

Authors:  F Hoffmann
Journal:  Klin Monbl Augenheilkd       Date:  1976-11       Impact factor: 0.700

7.  Penetrating keratoplasty in acute herpetic corneal performations.

Authors:  J T Patten; H D Cavanagh; D Pavan-Langston
Journal:  Ann Ophthalmol       Date:  1976-03

8.  Changing indications for keratoplasty.

Authors:  J J Arentsen; B Morgan; W R Green
Journal:  Am J Ophthalmol       Date:  1976-03       Impact factor: 5.258

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.